Objective: The aim of the idiopathic granulomatous mastitis (IGM) consensus study was to evaluate the etiology, diagnostic steps, and differential diagnosis and propose a widely accepted clinical classification of this mysterious breast disease. Method: The organization of a national IGM consensus was decided by the joint evaluation of the Turkish Federation of Breast Diseases Societies, SENATURK, and the Society of Breast Surgery. First, a working group of 11 members was formed, and a survey and workshop were organized to reach a common consensus. The modified Delphi method was used in the consensus methodology. Voting rates of 80% and above were considered as acceptance. Results: The consensus was 45/50 (92%) that core needle biopsies are necessary for the diagnosis of IGM and 39/40 (97%) that a new clinical classification is needed. The proposed Turkish clinical classification of IGM was accepted by 94% in three rounds of voting. Conclusion: This disease should be considered etiologically idiopathic. Tissue diagnosis and pathological evaluation are recommended for treatment. The proposed IGM Turkey classification was strongly accepted.

Idiopathic granulomatous mastitis is a highly heterogeneous group of diseases. There is ongoing controversy regarding the etiology, clinical classification, and treatment algorithm of the disease. There is no common terminological language for the clinical signs and symptoms of the disease. Treatment algorithms are diverse, and there is no standardization. Scientific comparisons cannot be made precisely due to the inclusion of heterogeneous groups in studies. Since there is no consensus on the severity of the disease, the types of treatment do not allow for comparisons between groups with the same clinical severity. These scientific limitations create difficulties in establishing national/international treatment algorithms or the acceptance of proposed algorithms. This consensus, prepared by our working group, defines a diagnostic algorithm for disease diagnosis and a terminological classification. The classification system, prepared according to disease severity, will be a pioneer in comparing patient groups and developing treatment algorithms.

1.
Kessler
E
,
Wolloch
Y
.
Granulomatous mastitis: a lesion clinically simulating carcinoma
.
Am J Clin Pathol
.
1972
;
58
(
6
):
642
6
.
2.
Dobinson
HC
,
Anderson
TP
,
Chambers
ST
,
Doogue
MP
,
Seaward
L
,
Werno
AM
.
Antimicrobial treatment options for granulomatous mastitis caused by Corynebacterium species
.
J Clin Microbiol
.
2015
;
53
(
9
):
2895
9
.
3.
Degnim
AC
,
Brahmbhatt
RD
,
Radisky
DC
,
Hoskin
TL
,
Stallings-Mann
M
,
Laudenschlager
M
, et al
.
Immune cell quantitation in normal breast tissue lobules with and without lobulitis
.
Breast Cancer Res Treat
.
2014
;
144
(
3
):
539
49
.
4.
Gulluoglu
BM
.
Idiopathic granulomatous mastitis: do we really regard it as a surgical disease anymore
.
World J Surg
.
2015
;
39
(
11
):
2724
5
.
5.
Papila Kundaktepe
B
,
Velidedeoğlu
M
,
Mete
B
.
The effect of methotrexate monotherapy on treatment-resistant idiopathic granulomatous mastitis patients
.
Surgeon
.
2022
;
20
(
3
):
e13
9
.
6.
Pluguez-Turull
CW
,
Nanyes
JE
,
Quintero
CJ
,
Alizai
H
,
Mais
DD
,
Kist
KA
, et al
.
Idiopathic granulomatous mastitis: manifestations at multimodality imaging and pitfalls
.
Radiographics
.
2018
;
38
(
2
):
330
56
.
7.
Hasbahceci
M
,
Kadioglu
H
.
Use of imaging for the diagnosis of idiopathic granulomatous mastitis: a clinician’s perspective
.
J Coll Physicians Surg Pak
.
2018
;
28
(
11
):
862
7
.
8.
Durur-Subasi
I
.
Diagnostic and interventional radiology in idiopathic granulomatous mastitis
.
Eurasian J Med
.
2019
;
51
(
3
):
293
7
.
9.
Yaghan
RJ
,
Ayoub
NM
,
Hamouri
S
,
Al-Mohtaseb
A
,
Gharaibeh
M
,
Yaghan
L
, et al
.
The role of establishing a multidisciplinary team for idiopathic granulomatous mastitis in improving patient outcomes and spreading awareness about recent disease trends
.
Int J Breast Cancer
.
2020
;
2020
:
5243958
.
10.
Cheng
J
,
Ding
H
,
Du
Y
,
Wu
X
,
Dai
X
.
Granlllomatous loblllar mastitis, mammary duct ectasia and erythema nodosmn: a cliIlicopathologic study of 4 cases with review of literature (in Chinese)
.
Chin J Diagn Pathol
.
2014
;
21
(
08
):
488
90
.
11.
Altintoprak
F
,
Kivilcim
T
,
Ozkan
OV
.
Aetiology of idiopathic granulomatous mastitis
.
World J Clin Cases
.
2014
;
2
(
12
):
852
8
.
12.
Irkorucu
O
.
Granulomatous mastitis: we need a useful classification system
.
Am J Surg
.
2018
;
216
(
3
):
642
.
13.
Yaghan
R
,
Hamouri
S
,
Ayoub
NM
,
Yaghan
L
,
Mazahreh
T
.
A proposal of a clinically based classification for idiopathic granulomatous mastitis
.
Asian Pac J Cancer Prev
.
2019
;
20
(
3
):
929
34
.
14.
Yuan
QQ
,
Xiao
SY
,
Farouk
O
,
Du
YT
,
Sheybani
F
,
Tan
QT
, et al
.
Management of granulomatous lobular mastitis: an international multidisciplinary consensus (2021 edition)
.
Mil Med Res
.
2022
;
9
(
1
):
20
.
15.
Kaviani
A
,
Vasigh
M
,
Omranipour
R
,
Mahmoudzadeh
H
,
Elahi
A
,
Farivar
L
, et al
.
Idiopathic granulomatous mastitis: looking for the most effective therapy with the least side effects according to the severity of the disease in 374 patients in Iran
.
Breast J
.
2019
;
25
(
4
):
672
7
.
16.
Alsaleh
N
.
Assertive clinical practice in managing patients with idiopathic granulomatous mastitis: review of literature
.
Ann Med Surg
.
2021
;
70
:
102792
801
.
17.
Bogach
J
,
Sriskandarajah
A
,
Wright
FC
,
Look Hong
N
,
Canadian Phyllodes Tumor Consen, sus Panel
.
Phyllodes tumors of the breast: Canadian national consensus document using modified Delphi methodology
.
Ann Surg Oncol
.
2023
;
30
(
11
):
6386
97
.
18.
Dilaveri
C
,
Degnim
A
,
Lee
C
,
DeSimone
D
,
Moldoveanu
D
,
Ghosh
K
.
Idiopathic granulomatous mastitis
.
Breast J
.
2024
;
2024
:
6693720
.
19.
Wolfrum
A
,
Kümmel
S
,
Theuerkauf
I
,
Pelz
E
,
Reinisch
M
.
Granulomatous mastitis: a therapeutic and diagnostic challenge
.
Breast Care
.
2018
;
13
(
6
):
413
8
.
20.
Ucar
EA
,
Durur-Subasi
I
,
Yilmaz
KB
,
Arikok
AT
,
Hekimoglu
B
.
Quantitative perfusion parameters of benign inflammatory breast pathologies: a descriptive study
.
Clin Imaging
.
2020
;
68
:
249
56
.
21.
Kayadibi
Y
,
Saracoglu
MS
,
Kurt
SA
,
Deger
E
,
Boy
FNS
,
Ucar
N
, et al
.
Differentiation of malignancy and idiopathic granulomatous mastitis presenting as non-mass lesions on MRI: radiological, clinical, radiomics, and clinical-radiomics models
.
Acad Radiol
.
2024
;
18
(
24
):
S1076
6332
.
22.
Wang
X
,
He
X
,
Liu
J
,
Zhang
H
,
Wan
H
,
Luo
J
, et al
.
Immune pathogenesis of idiopathic granulomatous mastitis: from etiology toward therapeutic approaches
.
Front Immunol
.
2024
;
15
:
1295759
.
23.
Zhang
M
,
Pu
D
,
Feng
D
,
Shi
G
,
Li
J
.
Rare and complicated granulomatous lobular mastitis (2000-2023): a bibliometrics study and visualization analysis
.
J Inflamm Res
.
2024
;
17
:
3709
24
.
24.
Koksal
H
,
Vatansev
H
,
Artac
H
,
Kadoglou
N
.
The clinical value of interleukins-8, −10, and −17 in idiopathic granulomatous mastitis
.
Clin Rheumatol
.
2020
;
39
(
5
):
1671
7
.
25.
Koksal
H
.
The clinical utility of autoantibodies in patients with idiopathic granulomatous mastitis
.
J Invest Surg
.
2022
;
35
(
2
):
325
9
.
26.
Saydam
M
,
Yilmaz
KB
,
Sahin
M
,
Yanik
H
,
Akinci
M
,
Yilmaz
I
, et al
.
New findings on autoimmune etiology of idiopathic granulomatous mastitis: serum IL-17, IL-22 and IL-23 levels of patients
.
J Invest Surg
.
2021
;
34
(
9
):
993
7
.
27.
Zhang
Q
,
Zhang
W
,
Lv
J
,
Zhang
Z
,
Zhao
Y
.
The effect of local steroid administration on idiopathic granulomatous mastitis: a systematic review andMeta-analysis
.
J Surg Res
.
2024
;
295
:
511
21
.
28.
Li
F
,
Nie
L
,
Huang
J
,
Sin
TH
,
Wang
X
,
Zhang
F
, et al
.
Evaluation of significantly changed chemokine factors of idiopathic granulomatous mastitis in non-puerperal patients
.
FASEB J
.
2024
;
38
(
13
):
e23745
.
You do not currently have access to this content.